Panel Discussion: Advancing Sample Management & Pre-Analytic Workflows for Robust, Reproducible Clinical Outcomes
- What are the main challenges and hurdles considering clinical sample and biomarker strategies to reduce downstream risk?
- What innovations in digital tools are facilitating end-to-end integrity and reproducibility?
- How are sponsors ensuring consistency in biospecimen handling when working across multiple CROs or laboratory partners?